FREmedica launches NIKKI Lyme wellness program through Ergopathics US network

Frequency Exchange Corp.'s wholly‑owned subsidiary FREmedica Technologies Inc. announced the market launch of its NIKKI Lyme wellness program via Ergopathics. Ergopathics will make the program available to therapists in its network of more than 7,000 therapy centres across the United States, allowing each centre to recommend or offer NIKKI Lyme at its discretion.

The agreement involves no minimum purchase requirements, participation guarantees or sales guarantees. Ergopathics reported positive feedback from a client survey indicating likely adoption of NIKKI in participating centres. Stephen Davis of Frequency Exchange called the rollout “an important commercial milestone” and said the partnership fills a diagnostic gap in the network’s current offerings. The initial rollout focuses on Lyme disease, with future NIKKI programs for sleep, stress, energy and regeneration possible pending market acceptance.